54 related articles for article (PubMed ID: 9523006)
21. The proline-rich sequence of CD3epsilon controls T cell antigen receptor expression on and signaling potency in preselection CD4+CD8+ thymocytes.
Mingueneau M; Sansoni A; Grégoire C; Roncagalli R; Aguado E; Weiss A; Malissen M; Malissen B
Nat Immunol; 2008 May; 9(5):522-32. PubMed ID: 18408722
[TBL] [Abstract][Full Text] [Related]
22. Diethylstilbestrol alters positive and negative selection of T cells in the thymus and modulates T-cell repertoire in the periphery.
Brown N; Nagarkatti M; Nagarkatti PS
Toxicol Appl Pharmacol; 2006 Apr; 212(2):119-26. PubMed ID: 16122773
[TBL] [Abstract][Full Text] [Related]
23. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
Barndt R; Dai MF; Zhuang Y
J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
[TBL] [Abstract][Full Text] [Related]
24. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation.
Vespa GN; Lewis LA; Kozak KR; Moran M; Nguyen JT; Baum LG; Miceli MC
J Immunol; 1999 Jan; 162(2):799-806. PubMed ID: 9916701
[TBL] [Abstract][Full Text] [Related]
25. The level of CD4 surface protein influences T cell selection in the thymus.
Frank GD; Parnes JR
J Immunol; 1998 Jan; 160(2):634-42. PubMed ID: 9551897
[TBL] [Abstract][Full Text] [Related]
26. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
Bot A; Casares S; Bot S; von Boehmer H; Bona C
J Immunol; 1998 May; 160(9):4500-7. PubMed ID: 9574556
[TBL] [Abstract][Full Text] [Related]
27. Unexpected reaction of anti-H-2d serum with thymic lymphoma cells derived from transgenic B6-H-2b TCR anti-HY/Db mice.
Matuszyk J; Zioło E; Kobzdej M; Strzadala L
Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):103-7. PubMed ID: 8915513
[TBL] [Abstract][Full Text] [Related]
28. T-cell receptor diversity prevents T-cell lymphoma development.
Newrzela S; Al-Ghaili N; Heinrich T; Petkova M; Hartmann S; Rengstl B; Kumar A; Jäck HM; Gerdes S; Roeder I; Hansmann ML; von Laer D
Leukemia; 2012 Dec; 26(12):2499-507. PubMed ID: 22643706
[TBL] [Abstract][Full Text] [Related]
29. Thymic lymphomas in interleukin 9 transgenic mice.
Renauld JC; van der Lugt N; Vink A; van Roon M; Godfraind C; Warnier G; Merz H; Feller A; Berns A; Van Snick J
Oncogene; 1994 May; 9(5):1327-32. PubMed ID: 8152793
[TBL] [Abstract][Full Text] [Related]
30. A Herpes saimiri oncogene causing peripheral T-cell lymphoma in transgenic mice.
Kretschmer C; Murphy C; Biesinger B; Beckers J; Fickenscher H; Kirchner T; Fleckenstein B; Rüther U
Oncogene; 1996 Apr; 12(8):1609-16. PubMed ID: 8622880
[TBL] [Abstract][Full Text] [Related]
31. The stromal gene encoding the CD274 antigen as a genetic modifier controlling survival of mice with γ-radiation-induced T-cell lymphoblastic lymphomas.
Santos J; González-Sánchez L; Villa-Morales M; Ors I; López-Nieva P; Vaquero C; González-Gugel E; Fernández-Navarro P; Roncero AM; Guenet JL; Montagutelli X; Fernández-Piqueras J
Oncogene; 2010 Sep; 29(38):5265-73. PubMed ID: 20639904
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of cell surface receptors and mitogen reactivity of individual spontaneous AKR lymphomas.
Nell LJ; Richie ER
Exp Hematol; 1981 Jul; 9(6):611-8. PubMed ID: 6973483
[TBL] [Abstract][Full Text] [Related]
33. Tumorigenicity of T lymphoma/T lymphoma hybrids and T lymphoma/normal cell hybrids.
Hays EF; Weinroth SE; MacLeod CL; Kitada S
Int J Cancer; 1986 Oct; 38(4):597-601. PubMed ID: 3759264
[TBL] [Abstract][Full Text] [Related]
34. BW5147 and Derivatives for the Study of T Cells and their Antigen Receptors.
White J; O'Brien RL; Born WK
Arch Immunol Ther Exp (Warsz); 2020 May; 68(3):15. PubMed ID: 32419056
[TBL] [Abstract][Full Text] [Related]
35. Identification of the transgenic integration site in 2C T cell receptor transgenic mice.
Son CY; Haines BB; Luch A; Ryu CJ
Transgenic Res; 2018 Oct; 27(5):441-450. PubMed ID: 30132177
[TBL] [Abstract][Full Text] [Related]
36. Growth regulation of a T-cell lymphoma via the T-cell receptor.
O'Neill HC
Leuk Res; 1994 Jan; 18(1):23-8. PubMed ID: 8289463
[TBL] [Abstract][Full Text] [Related]
37. TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate.
Hesterberg RS; Liu M; Elmarsafawi AG; Koomen JM; Welsh EA; Hesterberg SG; Ranatunga S; Yang C; Li W; Lawrence HR; Rodriguez PC; Berglund AE; Cleveland JL
Cancer Immunol Res; 2022 Oct; 10(10):1263-1279. PubMed ID: 35969234
[TBL] [Abstract][Full Text] [Related]
38. Establishment of a human T-lymphoma cell line (H-TL90) and analysis of its biological characteristics.
Shi L; Liu X; Zhang Y; Li X; Li D; Wang W
Chin Med Sci J; 1995 Sep; 10(3):178-80. PubMed ID: 8580490
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting TCR-repertoire diversity.
Wedderburn LR; Bowness P
Immunol Today; 1994 Jan; 15(1):41. PubMed ID: 8136012
[No Abstract] [Full Text] [Related]
40. Loss of T cell receptor diminished tumorigenicity of thymocyte-derived lymphoma cells in the T cell receptor transgenic mice.
Kobzdej M; Matuszyk J; Zioło E; Strzadała L
Arch Immunol Ther Exp (Warsz); 1997; 45(4):307-13. PubMed ID: 9523006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
